📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-07 17:59
122 analysed today
FollowTelegram
122
Today
149,523
All-time analysed
42,890
Positive
6,652
Negative
91,308
Neutral
8,605
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
4 announcements match the current filters (relevance ≥ 5).
Rs 17.23 Cr Revenue: Arvee Labs Reports 130% YoY Growth in Q1 FY27
Arvee Laboratories reported a strong start to FY27 with Q1 revenue from operations jumping 130% YoY to Rs 17.23 Cr. Net profit surged to Rs 1.69 Cr, a significant recovery from Rs 0.17 Cr in the year-ago period. The performance was heavily driven by the Non-textile segment, which contributed Rs 15.10 Cr (87%) to total revenue. Notably, the Board has postponed the previously proposed Scheme of Arrangement for further review.
Confidence: HIGH
What changedThe company achieved a sharp scale-up in quarterly revenue and profitability compared to both the previous year and the preceding quarter (Mar 2026 revenue was Rs 10.80 Cr).
Why it mattersFor a small-cap company with a TTM revenue of Rs 37 Cr, a single quarter generating Rs 17.23 Cr (46.5% of TTM) indicates a potential structural shift in demand or successful execution in the non-textile segment.
Q1 FY27 Revenue: Rs 17.23 CrQ1 Revenue vs TTM Revenue: 46.5%Q1 FY27 Net Profit: Rs 1.69 CrNon-textile Segment Revenue: Rs 15.10 CrYoY Revenue Growth: 130%
📅 Short termThe stock is likely to react positively to the substantial earnings beat and margin expansion in the immediate term.
📈 Long termIf the company maintains this quarterly run-rate, it could significantly exceed its FY26 annual revenue of Rs 31.51 Cr, potentially leading to a valuation re-rating.
⚠ Risk flags
- High segment concentration (Non-textile)
- Uncertainty regarding the postponed Scheme of Arrangement
- History of low pricing power as a price-taker
Key Highlights
Revenue from operations grew 130% YoY to Rs 17.23 Cr from Rs 7.48 Cr.
Net profit increased nearly 10-fold to Rs 1.69 Cr compared to Rs 0.17 Cr in Q1 FY26.
Non-textile segment revenue stood at Rs 15.10 Cr, dwarfing the Textile segment's Rs 2.31 Cr.
Quarterly EPS rose to Rs 1.54 from Rs 0.15 in the corresponding previous quarter.
Board postponed the Scheme of Arrangement to gain a 'better understanding of the matter'.
👀 What to Watch
Investors should monitor the sustainability of this higher revenue run-rate in upcoming quarters and seek clarity on the reasons for postponing the Scheme of Arrangement.
Arvee Laboratories FY26 Net Profit Rises 17.6% to ₹2.53 Cr Despite Annual Revenue Dip
Arvee Laboratories reported a mixed performance for the financial year ended March 31, 2026, with annual net profit growing to ₹252.63 lakhs from ₹214.74 lakhs in the previous year. While total annual revenue from operations saw an 18% decline to ₹3,151.41 lakhs, the fourth quarter showed a strong recovery with revenue jumping 67% year-on-year to ₹1,080.41 lakhs. The company's non-textile segment remains the primary revenue driver, contributing approximately 86% of the total turnover for the year. Earnings per share (EPS) improved to ₹2.29 from ₹1.95 in the prior fiscal year.
Key Highlights
Full-year net profit increased 17.6% to ₹252.63 lakhs compared to ₹214.74 lakhs in FY25.
Q4 FY26 revenue surged to ₹1,080.41 lakhs, a significant jump from ₹645.00 lakhs in Q4 FY25.
Annual EPS rose to ₹2.29 from ₹1.95, reflecting improved bottom-line efficiency.
Non-textile segment contributed ₹2,757.99 lakhs to annual revenue, significantly outperforming the textile segment.
Total assets grew to ₹4,325.71 lakhs as of March 31, 2026, up from ₹3,915.93 lakhs the previous year.
👀 What to Watch
Investors should focus on the strong Q4 recovery and improved profitability margins despite the annual revenue contraction. The growth in the non-textile segment is a key metric to watch for sustained long-term performance.
Arvee Laboratories Q3 FY26 Net Profit Surges to ₹1.83 Cr, Revenue Up 10% YoY
Arvee Laboratories reported a strong sequential and year-on-year recovery in Q3 FY26, with revenue reaching ₹977.95 Lakhs compared to ₹345.05 Lakhs in the previous quarter. Net profit for the quarter stood at ₹182.69 Lakhs, a significant jump from ₹15.48 Lakhs in Q3 FY25, though this was aided by a deferred tax credit of ₹66.09 Lakhs. Despite the strong quarter, the nine-month revenue of ₹2,071 Lakhs still lags significantly behind the ₹3,203.72 Lakhs recorded in the same period last year. The non-textile segment continues to be the primary revenue driver, contributing approximately 89% of the total quarterly income.
Key Highlights
Revenue from operations grew 9.8% YoY to ₹977.95 Lakhs in Q3 FY26.
Net Profit for the quarter increased to ₹182.69 Lakhs from ₹15.48 Lakhs in the previous year's corresponding quarter.
Quarterly Earnings Per Share (EPS) rose to ₹1.66 from ₹0.14 YoY.
Non-textile segment revenue dominated at ₹881.88 Lakhs, while the textile segment contributed ₹109.71 Lakhs.
Total expenses for the nine-month period decreased to ₹1,966.80 Lakhs from ₹2,970.93 Lakhs YoY.
👀 What to Watch
Investors should view the sharp sequential recovery in revenue and margins as a positive sign, but remain mindful of the overall decline in nine-month performance. Monitor the sustainability of the non-textile segment's growth as it is the critical driver for the company's profitability.
Arvee Laboratories Q3 PAT Surges to ₹1.83 Cr; Revenue Up 10% YoY
Arvee Laboratories reported a strong recovery in Q3 FY26, with revenue from operations reaching ₹9.78 crore, a 10% increase compared to the same quarter last year and a massive 183% jump sequentially. Net profit saw a significant boost to ₹1.83 crore, aided by improved margins and a deferred tax credit of ₹66.09 lakhs. While the quarterly performance is robust, the nine-month revenue of ₹20.71 crore still trails the previous year's ₹32.04 crore, indicating a slow start to the fiscal year. The non-textile chemical segment continues to be the primary revenue driver, contributing approximately 90% of the total turnover.
Key Highlights
Revenue from operations grew 10% YoY to ₹977.95 lakhs and 183% QoQ from ₹345.05 lakhs.
Net Profit (PAT) rose sharply to ₹182.69 lakhs from ₹15.48 lakhs in the year-ago period.
Earnings Per Share (EPS) increased to ₹1.66 for the quarter compared to ₹0.14 YoY.
Non-textile segment contributed ₹881.88 lakhs to revenue with a segment profit of ₹126.94 lakhs.
Nine-month PAT stands at ₹200.61 lakhs, nearly matching the previous year's 9M figure of ₹207.82 lakhs despite lower revenue.
👀 What to Watch
Investors should note the strong sequential turnaround and margin improvement in the non-textile segment. While the quarterly growth is impressive, long-term positions should be weighed against the overall decline in 9-month revenue compared to the previous year.
